Figure 1.
Plasma mtDNA concentration of the patients treated with erlotinib on days 0, 15, 29 and at the time of disease progression (dpd). ∘Minor outliers; *extreme outliers; mtDNA, mitochondrial DNA.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.